Oppenheimer Sticks to Their Buy Rating for Viking Therapeutics (VKTX)
Why Viking Therapeutics, Inc. (VKTX) Dipped More Than Broader Market Today
Eli Lilly and Co (LLY.US) explores new uses for "miracle weight-loss drug" Zepbound, aiming to reduce the incidence of diabetes and other high-risk populations.
eli lilly and co is exploring new uses for its weight loss drug Zepbound to reduce the incidence of diabetes in high-risk populations, even if they are not overweight.
Lilly Looking to Test Zepbound as Health Maintenance Drug: Report
New Small-cap Buy and Sell Ideas for Oppenheimer's 50/50 List
Roche Sees Carmot Obesity Drugs' Potential Peak Sales at $3.6B+: Report
